SinoLIMS
Driven by national policies regarding genomic data sovereignty, Chinese biopharma companies strongly favor or are mandated to use domestic servers and localized software providers like SinoLIMS.
- Country
- China
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| digital-it | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaema
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| LIMS/ELN for bioproduction | digital-it | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.